Stock

Walgreens plans store closures as CEO says consumers ‘stunned’ by prices

Walgreens is planning potentially sweeping store closures as it faces what its CEO called a “challenging” environment for pharmacies and U.S. consumers.

The pharmacy chain on Thursday morning announced quarterly earnings that fell short of Wall Street expectations. Walgreens’ stock price dropped 22% on the day.

In an interview with CNBC, CEO Tim Wentworth said the company now forecasts weaker consumer spending for the rest of the year.

″We assumed…in the second half that the consumer would get somewhat stronger” but “that is not the case,’ Wentworth said. 

‘The consumer is absolutely stunned by the absolute prices of things, and the fact that some of them may not be inflating doesn’t actually change their resistance to the current pricing,’ he added. ‘So we’ve had to get really keen, particularly in discretionary things.’

Last month, Walgreens, following Target’s lead, announced plans to slash prices on some 1,300 items in response to better serve customers it said were increasingly under ‘financial strain.’

Wentworth didn’t state an exact number of closures, but implied it could be as much as 25% of the chain’s approximately 8,600 stores.

“75% of our stores drive 100% of our profitability today,” Wentworth said. “What that means is the others we take a hard look at, we are going to finalize a number that we will close.”

Walgreens has contended with difficulties for years.

The company’s share price has seen steady declines for about a decade, dropping from a peak of more than $95 a share in 2015 to less than $15 today. It’s reported reduced revenues from prescription drugs, and its retail offerings remain under pressure from both big-box chains and Amazon.com. And it already announced a plan to close 150 U.S. stores last summer.

Today, Walgreens is about one-third the size of chief rival, CVS, which has also been under pressure over the past two years.

Since the Covid 19 pandemic, Walgreens has seen a period of executive leadership turmoil: Wentworth was named CEO in October after his predecessor, Starbucks and Walmart veteran Rosalind Brewer, unexpectedly announced her departure from the role less than three years into the job.

A bright spot was its health-care segment, which topped revenue estimates. Walgreens views on-site medical services and specialty pharmacy offerings as critical to its ongoing push to transform from a major drugstore chain into a large health-care company. 

This post appeared first on NBC NEWS

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 GreatWallStreetPublisher.com

Exit mobile version